K
Originally published by Kenyans
📰 Read Full Article
top
June 5, 2026
2h ago

U.S. Unveils Experimental Ebola Treatment Amid Kenya Quarantine Resistance

U.S. Unveils Experimental Ebola Treatment Amid Kenya Quarantine Resistance

Patients exposed in neighbouring DRC will be prioritised in the treatment rollout, amid controversy over the airlifting of patients to the Laikipia facility...

✨ Key Highlights

The United States has authorized an experimental Ebola antibody treatment, MBP-134, for high-risk individuals amidst growing concerns over a proposed quarantine facility in Kenya.

  • The investigational therapy, MBP-134, has shown promise in animal studies and will be administered under emergency use protocols.
  • Key entities involved include the U.S. Department of Health and Human Services (HHS), Mapp Biopharmaceuticals, and the Biomedical Advanced Research and Development Authority (BARDA).
  • Protests have erupted in Laikipia County, Kenya, regarding the planned 50-bed bio-isolation facility, with residents citing safety and transparency concerns, despite assurances from the U.S. Embassy in Nairobi.

Continue Reading

Read the complete article from Kenyans

📰 Read Full Article
Advertisement
Advertisement